Accuray Incorporated logo

ARAYAccuray Incorporated

NASDAQ · Healthcare · Medical Devices

$0.25

-$0.00 (-1.10%)

Accuray Incorporated (ARAY) is a medical devices company listed on NASDAQ. It is led by Suzanne Winter M.B.A., based in 1240 Deming Way, Madison, WI, United States, 53717-1954, with about 987 employees. Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. It offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy platform, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.

Latest reported ARAY revenue for 2025-09-30 was $93.9M. Net income was -$21.7M. Revenue was down 79.5% from 2025-06-30 to 2025-09-30. ARAY currently screens at market cap $140.1M.

Use this ARAY page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the ARAY quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the ARAY SEC filings page. Lician reads the product cache first so this HTML stays unique to Accuray Incorporated even when a live quote feed is slow.

About Accuray Incorporated

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. It offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy platform, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.

ARAY Key Statistics

Market Cap

$140.10M

Volume

196,670

Previous Close

$0.27

Day Range

$0.27$0.29

00

EPS

-$0.02

Revenue

$458.50M

Net Income

-$1.59M

Gross Profit

$0.00

Free Cash Flow

$0.00

Revenue Growth

+2.7%

Profit Margin

-0.3%

Employees

987

ARAY Financials

Annual income statement in USD. Latest reported periods first.

ARAY annual income statement across FY2025, FY2024, FY2023, FY2022
LineFY2025FY2024FY2023FY2022
Revenue$458.50M$446.55M$447.61M$429.91M
Cost of Revenue$0.00$0.00$0.00$0.00
Gross Profit$0.00$0.00$0.00$0.00
Operating Income$0.00$0.00$0.00$0.00
Net Income-$1.59M-$15.54M-$9.28M-$5.35M
EPS (Diluted)-$0.02-$0.16-$0.10-$0.06

Total Assets

$470.24M

Total Debt

$0.00

Shareholders' Equity

$0.00

Cash & Equivalents

$57.42M

Operating Cash Flow

$2.86M

Free Cash Flow

$0.00

Accuray Incorporated Company Information

President, CEO & Director
Suzanne Winter M.B.A.
Headquarters
1240 Deming Way, Madison, WI, United States, 53717-1954
Phone
608 824 2800
IPO / Founded
2007-02-08
Industry
Medical Devices
Data Updated:

Upcoming Events for ARAY